Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025
-
Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study
-
Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference
-
EyePoint Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Developments
-
Astec Reports Second Quarter 2025 Results
-
American Shared Hospital Services Announces Second Quarter Financial Results Conference Call
-
Hopewell Fund Announces Anna Brower as Inaugural President
-
Mingteng International’s Subsidiary Entered into Strategic Cooperation Framework Agreement with Suzhou Lvkon Transmission Technology to Strengthen Partnership and Enhance Competitiveness in the New
-
Royalty Pharma Reports Second Quarter 2025 Results
-
Coda Octopus Group Announces that it has recently received an accreditation for ISO:17025 from the United Kingdom Accreditation Services (UKAS) for its ultrasonic calibration services.
-
White Gold Corp. Commences Diamond Drilling on Flagship High Grade White Gold Project
-
Inventus Reports 4.18 gpt Gold and 1.48 Metre Average for Initial Trench 1 North Grade Control Drilling and Provides Update on Bulk Sample Operation
-
OTC Markets Group Welcomes Alkane Resources Limited to OTCQX
-
Trident Resources to Commence Inaugural 5,000m Drill Program at Contact Lake High-Grade Gold Project, Saskatchewan
-
Arvinas Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress
-
BioXcel Therapeutics Announces Publication in Frontiers in Pharmacology on the Effects of Dexmedetomidine (the active ingredient in BXCL-501) on Stress-Mediated Behaviors in Non-clinical Studies
-
Telesat Reports Results for the Quarter and Six Months Ended June 30, 2025
-
Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025
-
Dayforce Reports Second Quarter 2025 Results¹
-
Energous Corporation Announces 1-for-30 Reverse Stock Split
-
Reminder - Stella-Jones Will Hold a Conference Call to Discuss Its Second Quarter Results
-
Entrada Therapeutics Reports Second Quarter 2025 Financial Results
-
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results
-
OMass Therapeutics Appoints Carol A. Schafer as Non-Executive Director and Chair of the Audit Committee
-
FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
-
30.1% Gross Margin and Lower Operating Expenses Enable Orion to Generate Positive Adjusted EBITDA on Q1’26 Revenue of $19.6M; Reiterates FY 2026 Outlook
-
YieldMax® ETFs Announces Distributions on ULTY, TSMY, YBIT, LFGY, YMAX, and Others
-
Wabash and Excel Truck Group Expand Trailer Partnership into the Carolinas
-
Finstar: 2025 Charity Month to Launch
-
MRC Global Announces Second Quarter 2025 Results
-
Brookfield Asset Management Announces Strong Second Quarter Results
-
Descartes Helps Reduce False Positives with AI-Enabled Denied Party Screening Solution
-
Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent
-
Fortrea Reports Second Quarter 2025 Results
-
Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038
-
Magnera Reports Third Quarter Results – Provides Updated Outlook
-
Smart Powerr Corp. Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
UCLOUDLINK Group Inc. to Report Second Quarter 2025 Financial Results on August 13, 2025
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former or Current 3M Company (NYSE:MMM) Investors Who Received Neogen Corporation (NASDAQ:NEOG) Shares in Connection With Neogen Corporation’s
-
Hut 8 Subsidiary American Bitcoin Announces Commencement of Gryphon Stockholder Voting on Go-Public Transaction
-
Fusion Fuel Regains Compliance with Nasdaq Listing Requirements
-
Parsons Reports Strong Second Quarter 2025 Results
-
Release of Marimekko's Half-year Financial Report, 1 January–30 June 2025
-
WeRide Launches 24/7 Robotaxi Testing in Beijing, Advances Towards Full-Day Service
-
Taboola Reports Strong Q2 2025 Financial Results, Surpassing High-End of Guidance; Increases Full-Year Guidance & Announces $200M Share Repurchase Expansion
-
Taboola Reports Strong Q2 2025 Financial Results, Surpassing High-End of Guidance; Increases Full-Year Guidance & Announces $200M Share Repurchase Expansion
-
CoinShares XBT Provider AB (Publ) Publishes Half Year Interim Report 2025
